Cargando…

The Pharmaceutical Company Approach to Antibiotic Policies

Detalles Bibliográficos
Autor principal:	White, Anthony R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120412/ http://dx.doi.org/10.1007/0-387-22852-7_34

Ejemplares similares

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

Pharmacovigilance obligations of the pharmaceutical companies in India
por: Arora, Deepa
Publicado: (2008)

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
por: Booth, Amy, et al.
Publicado: (2023)

Unmet Medical Needs and the Role of Pharmaceutical Companies
por: Meyer-Sabellek, Wolfgang
Publicado: (2009)

Legislative, educational, policy and other interventions targeting physicians’ interaction with pharmaceutical companies: a systematic review
por: Alkhaled, Lina, et al.
Publicado: (2014)

Error in Payments From Some Pharmaceutical Companies
Publicado: (2019)

Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care
por: Fernández-Álvarez, Iria, et al.
Publicado: (2019)

Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017)

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2014)

A survey of pharmaceutical company representative interactions with doctors in Libya
por: Alssageer, Mustafa A., et al.
Publicado: (2012)

The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland
por: Heiskanen, Kati, et al.
Publicado: (2017)

Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
por: Smith, Richard
Publicado: (2005)

Ten Simple Rules for Internship in a Pharmaceutical Company
por: Chen, Bin
Publicado: (2014)

Pharmaceutical companies as the funding sources for continuing medical education
por: Kanchan, Tanuj
Publicado: (2015)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

Doctors’ opinions of information provided by Libyan pharmaceutical company representatives
por: Alssageer, Mustafa A., et al.
Publicado: (2012)

Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
por: Gurgula, Olga
Publicado: (2020)

The optimization of overall equipment effectiveness factors in a pharmaceutical company
por: Chikwendu, Okpala Charles, et al.
Publicado: (2020)

Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies
por: López-Toro, Alberto A., et al.
Publicado: (2021)

Country versus pharmaceutical company interests for hepatitis C treatment
por: Lothan, Roy, et al.
Publicado: (2022)

What are the obligations of pharmaceutical companies in a global health emergency?
por: Emanuel, Ezekiel J, et al.
Publicado: (2021)

Managing robotics in the bioanalytical/metabolic environment of a pharmaceutical company
por: Kushinsky, Stanley
Publicado: (1991)

The Effect of Capital Structure on the Profitability of Pharmaceutical Companies The Case of Iran
por: Mohammadzadeh, Mehdi, et al.
Publicado: (2013)

Do companies in the pharmaceutical supply chain earn excess returns?
por: Sood, Neeraj, et al.
Publicado: (2021)

Quality Decision-Making Practices in Pharmaceutical Companies and Regulatory Authorities: Current and Proposed Approaches to Its Documentation
por: Bujar, Magdalena, et al.
Publicado: (2020)

Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models
por: Ferrara, Joseph
Publicado: (2007)

Regulation of Clinical Research Sponsored by Pharmaceutical Companies: A Proposal
por: Sotelo, Julio
Publicado: (2006)

Pharmaceutical company perspectives on current safety risk communications in Japan
por: Urushihara, Hisashi, et al.
Publicado: (2014)

Good pharmacovigilance practice: Need of the hour from pharmaceutical companies
por: Bhati, Neha, et al.
Publicado: (2015)

Changing R&D models in research-based pharmaceutical companies
por: Schuhmacher, Alexander, et al.
Publicado: (2016)

The Role of Pharmaceutical Companies in Antimicrobial Stewardship: A Case Study
por: Hermsen, Elizabeth D, et al.
Publicado: (2020)

Making pharmaceutical companies report what matters about innovation
por: Cohen, Adam, et al.
Publicado: (2021)

Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
por: Mitchell, Aaron P, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6dmqtckkhugjjsucbh70fj24ad